ArticleOxidative medicine and cellular longevity2021

THAP9-AS1 Promotes Tumorigenesis and Reduces ROS Generation through the JAK2/STAT3 Signaling Pathway by Increasing SOCS3 Promoter Methylation in Osteosarcoma.

Shuai Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.